| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CLO &Secretary | Chief Legal Officer & | Chief Legal Officer & +1 more
2 companies
Reardon Andrew is a CLO &Secretary at LGNZZ with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $6.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2025 | LGND Ligand Pharmaceuticals Inc | CLO &Secretary | Sell | 500 | $114.08 | $57,042.15 | -1.5% | +48.5% | - | |
| Jun 10, 2025 | LGND Ligand Pharmaceuticals Inc | CLO &Secretary | Sell | 500 | $114.54 | $57,270.70 | -1.5% | +46.2% | - | |
| May 15, 2025 | LGND Ligand Pharmaceuticals Inc | CLO &Secretary | Sell | 1,000 | $104.00 | $104,000.00 | -2.9% | +50.8% | - | |
| Sep 23, 2024 | LGND Ligand Pharmaceuticals Inc | CLO &Secretary | Sale+OE | 2,000 | $99.60 | $199,201.00 | -8.2% | +14.2% | +71.2% | |
| Aug 28, 2024 | LGND Ligand Pharmaceuticals Inc | CLO &Secretary | Sale+OE | 1,500 | $106.39 | $159,590.55 | -6.2% | +16.7% | +50.1% | |
| May 9, 2024 | LGND Ligand Pharmaceuticals Inc | Chief Legal Officer & | Sale+OE | 10,000 | $83.04 | $830,449.00 | -31.1% | +8.4% | +21.3% | |
| Mar 24, 2023 | LGND Ligand Pharmaceuticals Inc | See Remarks | Sell | 300 | $69.92 | $20,977.29 | -1.8% | +9.1% | +2.3% |